Arbutus Biopharma Corp Cash Equivalents, at Carrying Value
Arbutus Biopharma Corp (ABUS) had Cash Equivalents, at Carrying Value of $8.90 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-12
- 2026-06-30: Cash Equivalents, at Carrying Value $8.90M.
- 2026-03-31: Cash Equivalents, at Carrying Value $14.49M.
- 2025-12-31: Cash Equivalents, at Carrying Value $10.22M.
- 2025-09-30: Cash Equivalents, at Carrying Value $7.84M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $8.90M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $14.49M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $10.22M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $7.84M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $30.40M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $26.38M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $29.53M 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |